- Morgan Stanley delivered a strong Q3 2025 with $18.2B revenue and $2.80 EPS as net income rose about 45% year over year, led by trading, investment banking, and wealth management.
- Its equities trading rebounded sharply, with $4.1B in revenue that topped Goldman Sachs’s $3.7B and highlighted a stronger markets franchise.
- Shares trade at a high-teens P/E with a 2.4%–2.9% dividend yield and ~43% payout ratio, implying moderate upside with income support.
- Key risks are macro and rate shocks that can compress valuation and weaken deal activity, trading, and other cyclical banking revenues.
Read More
The primary article correctly captures the essence of Morgan Stanley as a long-term, dividend-paying institution rather than a speculative meme stock. Recent financials (Q3 2025) substantiate the narrative, with revenue of $18.2B (+18% YoY), $4.6B net income (+45% YoY), and EPS of $2.80 (+49%) largely beating Wall Street expectations—especially in equities trading where MS outperformed Goldman Sachs.
On the valuation front, MS is trading at a P/E in the high-teens. According to Digrin, MS has a trailing P/E of roughly 17.9×, forward P/E somewhat lower, and dividend yields in the 2.4–2.9% range. That aligns with industry norms for diversified financial institutions combining wealth management, capital markets, and institutional banking.
The business mix is both a strength and a source of risk. Morgan Stanley’s diversified exposure—wealth management (which continues to gather net new assets), investment banking and trading—offers multiple levers for growth. However, this also means exposure to interest rate volatility, capital markets distress, and macroeconomic policy shocks. Prior research reports highlight risks from tariffs and recession possibilities disrupting banking growth and increasing loan losses and pressuring investment banking fees.
Strategically, MS seems positioned to continue as a core portfolio holding for investors prioritizing income and stability. It delivers a strong earnings profile, controlled payout, and leverage in favorable capital markets. In a bullish macro scenario—with easing interest rates or increased deal activity—the upside is meaningful. However, for volatile, speculative-focused investors seeking rapid growth or high short-term returns, MS may underdeliver.
Open questions include: (a) how MS will manage costs amid rising rates and compensation pressures; (b) sustainability of investment banking and trading revenues if macro shocks materialize; (c) how much upside remains in valuation if P/E multiples compress further; (d) what guidance company leadership is giving for capital allocation and dividend policy in 2026.
Supporting Notes
- In Q3 2025, Morgan Stanley generated $18.2B in net revenue, with net income of $4.6B and EPS of $2.80, up ~45% YoY.
- Equities trading revenue in Q3 2025 rose ~35% YoY to $4.1B, overtaking Goldman Sachs’s $3.7B in the same business.
- Wealth management attracted $81B in net new assets in Q3, indicating strong inflow momentum.
- Dividend yield is in the range of 2.4%–2.9%; trailing P/E is approximately 17–18×; payout ratio near 43%.
- Analysts’ targets are mixed: Wolfe Research upgraded MS to “Outperform” with a target of ~$198, whereas others are more cautious or even see slight downside, with targets in the ~$160–$185 range.
- Risks cited in recent analyst reports include recession risk from tariff policy, rising interest rates, weak loan growth, and pressure on investment banking revenues.